✦ LIBER ✦

871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

✍ Scribed by Mauss, S.; Boeker, K.H.W.; Eisenbach, C.; Moeller, B.; Moog, G.; Lutz, T.; Naumann, U.; Christensen, S.; Jung, M.-C.; Teuber, G.; Frank Doss, M.; Schuchmann, M.; Schott, E.; Alshuth, U.; Hueppe, D.

Book ID: 123214996
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 72 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60873-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

875 REAL-WORLD EFFICACY AND SAFETY OF BO

875 REAL-WORLD EFFICACY AND SAFETY OF BOCEPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

✍ Moog, G.; Schober, A.; Antoni, C.; Bruch, H.R.; Herrmann, A.; John, C.; Steffens 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 74 KB

908 REAL-WORLD EFFICACY OF BOCEPREVIR IN

908 REAL-WORLD EFFICACY OF BOCEPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN TREATMENT-EXPERIENCED PATIENTS: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

✍ Spengler, U.; Schober, A.; John, C.; Bruch, H.R.; Heyne, R.; Antoni, C.; Herrman 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

P1150 BASELINE CHARACTERISTICS AND TREAT

P1150 BASELINE CHARACTERISTICS AND TREATMENT EFFICACY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2a AND RIBAVIRIN IN 253 HCV GENOTYPE 1 NONRESPONDER PATIENTS IN A REAL-WORLD SETTING

✍ Hofmann, W.P.; Mauss, S.; Baumgarten, A.; Boeker, K.H.W.; Link, R.; Naumann, U.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

601 EFFICACY AND SAFETY OF PEGINTERFERON

601 EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A 360 μG/WEEK IN COMBINATION WITH RIBAVIRIN IN HEPATITIS C GENOTYPE 1 PATIENTS WITH CIRRHOSIS: ANALYSIS FROM THE CHARIOT STUDY

✍ W.S.C. Cheng; S. Roberts; M. Weltman; D.H.G. Crawford; W. Sievert; G. McCaughan; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

274 IMPROVED SUSTAINED VIROLOGIC RESPONS

274 IMPROVED SUSTAINED VIROLOGIC RESPONSE (SVR) RATES IN “DIFFICULT-TO-CURE” PATIENTS TREATED WITH TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN: AN ANALYSIS FROM THE PROVE3 STUDY

✍ M.P. Manns; A.J. Muir; N. Adda; J.G. McHutchison; N. Terrault; L. Bengtsson; S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Safety and efficacy of combination thera

Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection

✍ Thierry Fontanges; Sylvain Beorchia; Catherine Douvin; Patrick Delassalle; Jean- 📂 Article 📅 2007 🏛 Masson Editeur 🌐 French ⚖ 996 KB